CRISPR Fingers Drug-Resistant Microbes in a ‘FLASH’
A research team led by scientists at UC San Francisco and the Chan Zuckerberg Biohub has developed a new CRISPR-based diagnostic tool, dubbed FLASH, that can rapidly identify any drug-resistant
University of California San Francisco
Give to UCSF
Training Computers to Think More Like Scientists
Chuang and Keiser have shown how machine learning could lead scientists astray and how scientists might, in the future, avoid some of the pitfalls of training computers to be scientists.
‘Undruggable’ Parkinson’s Molecule Spills Its Secrets
UCSF researchers developed a strategy for targeting a key molecule implicated in Parkinson’s disease, opening up a potential new treatment strategy for the currently incurable movement disorder.
Not Just Neurons: Precision Signaling Architecture Discovered in Non-Neural Cells that Direct Development
UCSF lab found that a chemical that acts as a neurotransmitter in the nervous system is essential for cytonemes to mediate cell-to-cell communication between non-neural cells.
UCSF’s Top NIH-Funded Projects of 2018
More than a thousand projects across the University received federal funding from the National Institutes of Health in 2018, totaling more than $647.8 million.
‘Virtual Pharmacology’ Advance Tackles Universe of Unknown Drugs
Scientists at UCSF, in collaboration with colleagues at UNC, have developed the world’s largest virtual pharmacology platform and shown it is capable of identifying extremely powerful new drugs.
For Women Scientists in Developing Nations, UCSF Fellowship Builds Confidence and Connections
The first recipient of QBI's Scholarship for Women from Developing Nations in Biosciences returns to Uganda with tools for success.
New Nursing and Pharmacy Partnership Aims to Expand Access to Mental Health Care
The Dyad project will help address the shortage of mental health providers in California and support a team-based approach to clinical medicine.
Drug Hobbles Deadly Liver Cancer by Stifling Protein Production
In laboratory experiments, UCSF researchers successfully beat back the growth of aggressive liver cancers using a surprising new approach.
Drug Targets for Ebola, Dengue, and Zika Viruses Found in Lab Study
Scientists identified key ways Ebola, Dengue, and Zika viruses hijack the body’s cells, and they found at least one potential drug that can disrupt this process in human cells.
CRISPR Joins Battle of the Bulge, Fights Obesity Without Edits to Genome
A weighty new study shows that CRISPR therapies can cut fat without cutting DNA.
New ‘SLICE’ Tool Can Massively Expand Immune System’s Cancer-Fighting Repertoire
UCSF researchers have devised a CRISPR-based system called SLICE, which will allow scientists to rapidly assess the function of each and every gene in “primary” immune cells.
‘Orphan’ RNAs Make Cancer Deadlier, But Potentially Easier to Diagnose
UCSF demonstrates that cancer is a clever engineer, capable of constructing entirely new disease-promoting networks out of raw materials readily available in the cell.
With Disease Agnostic Approach, QBI is Accelerating Ambitious Science
The Quantitative Biosciences Institute attracts investigators on the basis of the tools and techniques they employ, rather than the diseases they study.
UCSF Immunology, Neuroscience Research Highly Ranked Among US News’ Best Global Universities
Seven UCSF research subject areas were ranked in the top 10 globally by US News & World Report.
